Prognostic significance of CXCL12 expression in patients with colorectal carcinoma.
about
The Role of Chemokines in Promoting Colorectal Cancer Invasion/MetastasisMolecular and pathogenetic aspects of tumor budding in colorectal cancerT cell exclusion, immune privilege, and the tumor microenvironmentCXC chemokines in cancer angiogenesis and metastasesIdentification of endogenous control genes for normalisation of real-time quantitative PCR data in colorectal cancer.Correlation effect of EGFR and CXCR4 and CCR7 chemokine receptors in predicting breast cancer metastasis and prognosis.CXCL12 expression by healthy and malignant ovarian epithelial cells.Histone hypoacetylation contributes to CXCL12 downregulation in colon cancer: impact on tumor growth and cell migration.Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer.In vitro migration of cytotoxic T lymphocyte derived from a colon carcinoma patient is dependent on CCL2 and CCR2.Cytokines, chemokines, and chemokine receptors quantitative expressions in patients with ovarian cancerSurvival outcomes in endometrial cancer patients are associated with CXCL12 and estrogen receptor expression.CXC chemokine ligand 12/stromal cell-derived factor-1 regulates cell adhesion in human colon cancer cells by induction of intercellular adhesion molecule-1A meta-analysis of CXCL12 expression for cancer prognosis.Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget.CAR T-cell immunotherapy: The path from the by-road to the freeway?Relationship between SDF-1G801A polymorphism and its expression in Tunisian patients with colorectal cancer.Visfatin induces stromal cell-derived factor-1 expression by β1 integrin signaling in colorectal cancer cells.The role of CXCR3 and CXCR4 in colorectal cancer metastasis.CXCR4, CXCL12 and the relative CXCL12-CXCR4 expression as prognostic factors in colon cancer.Invasive front of colorectal cancer: dynamic interface of pro-/anti-tumor factors.A prognostic model comprising pT stage, N status, and the chemokine receptors CXCR4 and CXCR7 powerfully predicts outcome in neoadjuvant resistant rectal cancer patients.Rho GTPase effectors and NAD metabolism in cancer immune suppression.Biological/pathological functions of the CXCL12/CXCR4/CXCR7 axes in the pathogenesis of bladder cancer.Association of plasma visfatin with risk of colorectal cancer: An observational study of Chinese patients.ADAM17 is a Tumor Promoter and Therapeutic Target in Western Diet-associated Colon Cancer.Explaining the Paucity of Intratumoral T Cells: A Construction Out of Known Entities.Reporting in studies of protein biomarkers of prognosis in colorectal cancer in relation to the REMARK guidelines.Clinicopathologic Significance of CXCL12 and CXCR4 Expressions in Patients with Colorectal Cancer.Profiles of alternative splicing in colorectal cancer and their clinical significance: A study based on large-scale sequencing data
P2860
Q26748194-4C6E105A-6354-477E-8EF6-0EF4131CF91EQ28085313-734560B9-22A4-444B-BF5A-632FC205B1A8Q28259872-EE7C2C41-F21A-4563-AE67-CE6B6AF7D76AQ30432791-6294D7C9-DEB5-4F23-9BEE-2739EECA5F7FQ33528155-C3D3F16C-4F8A-4B9E-A8FC-B8EAC0BE0A8BQ33751824-DCA3D6A3-0330-4B7E-98AB-44D413C434C7Q33848551-922E6C99-C455-4338-8B40-52B40D91EC15Q33888795-DB19B8D1-BB59-44C1-9565-03AFDB2A994CQ34387974-B44A318D-837A-4436-822A-7CAAB4CDE4E5Q34790338-7EF9F222-36CD-4AD1-BEE0-2013190877B9Q35604189-BE93609D-A721-409B-84A0-5202D3606FC3Q35794892-05B4B35C-9AE3-442A-98A0-BF64D12ACC67Q36369111-84187C82-B1F4-42B1-A49C-D38346644729Q36378583-78E6C883-E042-42F6-B504-34733E2F3352Q37840946-3F51910C-5D0B-47FF-B94A-5E48E4244B26Q38632105-B97C7B07-E362-4244-A80E-D32059D8E96CQ38872037-CED0556E-C5B1-4449-9DAE-CA84C14F78A5Q39264457-5D1AFEBD-1395-41B9-BE59-3DD6910D2577Q39332870-4018B567-4D34-487E-8DE1-344D86862A00Q41041246-3462CB9F-E088-4D57-AF5C-279E4604EDC9Q42951434-044C0A5D-4944-4A66-8867-EF263BAA544FQ44412713-C6BA57D9-EA3F-4B71-ADC2-D7537BB7C2DFQ45974765-924CE4EA-D623-47FF-A0EA-3B4FD022D59BQ47664682-6794E110-3688-4BC3-AC87-8F22DAEB7F10Q47873798-B930ADCF-4096-4DD7-A678-68DDAC7154B0Q49307913-141525AA-1CEB-4344-87E6-E63DBFC35322Q53369837-7EBB3EDA-7C89-4FAD-85AD-0C9BE9892A8AQ53584232-2536D933-1EE8-4DFD-8C66-708B4EC90DDCQ55019874-323EA7DA-C5DC-427B-B1E8-EA4D42436EFAQ58714868-47B69060-2253-461A-8755-D26531B6639F
P2860
Prognostic significance of CXCL12 expression in patients with colorectal carcinoma.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Prognostic significance of CXCL12 expression in patients with colorectal carcinoma.
@en
Prognostic significance of CXCL12 expression in patients with colorectal carcinoma.
@nl
type
label
Prognostic significance of CXCL12 expression in patients with colorectal carcinoma.
@en
Prognostic significance of CXCL12 expression in patients with colorectal carcinoma.
@nl
prefLabel
Prognostic significance of CXCL12 expression in patients with colorectal carcinoma.
@en
Prognostic significance of CXCL12 expression in patients with colorectal carcinoma.
@nl
P2093
P2860
P356
P1476
Prognostic significance of CXCL12 expression in patients with colorectal carcinoma.
@en
P2093
Setsuo Hirohashi
Yoshihiro Moriya
Yoshinori Ino
Yukihiro Nakanishi
Yuri Akishima-Fukasawa
P2860
P304
202-10; quiz 307
P356
10.1309/AJCPK35VZJEWCUTL
P407
P577
2009-08-01T00:00:00Z